CompoAtlas

100% Pure & Natural Ylang Ylang Essential Oil

100% Pure & Natural Ylang Ylang Essential Oil, NPN 80141815: natural health product licensed in Canada. Medicinal ingredients: Cananga odorata.

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Cananga odorata

Source : Cananga odorata - Fleur

100 %

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 yearsNot specifiedNot specified

Uses authorised in Canada

Used in aromatherapy as a nervine/calmative.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
PUROLEO
Licence holder
Pureoyl Healthcare
NPN or DIN-HM
80141815
Status
Active licence
Licence date
13 June 2025
Revision date
Not provided
Form
Liquide
Route of administration
Inhalation et topique
Application type
Officinale

Source

Official Health Canada record, licence 80141815

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “100% Pure & Natural Ylang Ylang Essential Oil (Pureoyl Healthcare): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80141815-100-pure-natural-ylang-ylang-essential-oil, updated 13 June 2025.

Enter to analyse, Shift+Enter for a new line